Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BTMD

BTMD - Biote Corp Stock Price, Fair Value and News

$2.06-0.12 (-5.50%)
Market Closed

82/100

BTMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

82/100

BTMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.32

Target 3M

$2.59

Target 6M

$2.98

BTMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTMD Price Action

Last 7 days

-10.0%

Last 30 days

-23.1%

Last 90 days

-25.9%

Trailing 12 Months

-64.1%

BTMD RSI Chart

BTMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTMD Valuation

Market Cap

64.5M

Price/Earnings (Trailing)

1.89

Price/Sales (Trailing)

0.33

EV/EBITDA

3.12

Price/Free Cashflow

1.88

BTMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.32

Target 3M

$2.59

Target 6M

$2.98

BTMD Fundamentals

BTMD Revenue

Revenue (TTM)

195.6M

Rev. Growth (Yr)

-6.67%

Rev. Growth (Qtr)

-1.86%

BTMD Earnings

Earnings (TTM)

34.1M

Earnings Growth (Yr)

-23.49%

Earnings Growth (Qtr)

108.61%

BTMD Profitability

Operating Margin

75.05%

EBT Margin

15.72%

Return on Equity

-52.05%

Return on Assets

30.61%

Free Cashflow Yield

53.27%

BTMD Investor Care

Shares Dilution (1Y)

0.92%

Diluted EPS (TTM)

0.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025199.4M199.1M195.6M0
2024187.3M187.2M193.1M197.2M
2023172.7M180.6M184.1M185.4M
2022145.0M151.6M158.0M165.0M
2021122.3M128.0M133.7M139.4M
2020000116.6M
2019000110.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About Biote Corp

BTMD
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.
 CEO
 WEBSITEhttps://biote.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES186

Biote Corp Frequently Asked Questions

BTMD is the stock ticker symbol of Biote Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Biote Corp is 64.54 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BTMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether BTMD is over valued or under valued. Whether Biote Corp is cheap or expensive depends on the assumptions which impact Biote Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BTMD.

As of Wed Jan 28 2026, BTMD's PE ratio (Price to Earnings) is 1.89 and Price to Sales (PS) ratio is 0.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BTMD PE ratio will change depending on the future growth rate expectations of investors.